Table 3.
Variables in the Equation | ||||||
---|---|---|---|---|---|---|
Variables | Univariate analysis | Multivariate analysis | ||||
HR | 95%CI | p-value | HR | 95%CI | p-value | |
TUBA1C | 2.147 | 1.211–3.809 | 0.009* | 1.838 | 1.009–3.349 | 0.047* |
Sex | 1.153 | 0.703–1.891 | 0.572 | |||
Grade | 1.954 | 1.201–3.178 | 0.007* | 2.277 | 1.332–3.893 | 0.003* |
Age | 1.315 | 0.822–2.104 | 0.253 | |||
T stage | 0.807 | 0.461–1.411 | 0.452 | |||
N stage | 1.976 | 1.208–3.233 | 0.007* | 2.111 | 1.204–3.701 | 0.009* |
M stage | 1.720 | 0.420–7.050 | 0.451 | |||
TNM stage | 1.567 | 1.111–2.210 | 0.011* | 1.175 | 0.781–1.768 | 0.440 |
smoke | 0.687 | 0.082–5.742 | 0.729 | |||
alcohol | 0.687 | 0.082–5.742 | 0.729 | |||
diabetes | 1.018 | 0.196–5.288 | 0.983 | |||
p53 | 1.462 | 0.863–2.477 | 0.158 | |||
Hepatitis | 0.774 | 0.093–6.469 | 0.813 | |||
Ki67 | 0.868 | 0.505–1.492 | 0.609 |
Univariate and multivariate analyses of the factors correlated with Overall survival of PDAC patients.
P Statistically significant (P <0.05) PDAC, pancreatic ductal adenocarcinoma; HR, hazard ratio; CI, confidence interval; TNM, tumor-node-metastasis.